Health Care & Life Sciences » Biotechnology | Proteon Therapeutics Inc.

Proteon Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
2,948.00
-
-
-
115
Cost of Goods Sold (COGS) incl. D&A
27.00
-
57.00
123.00
148.00
115
Gross Income
27.00
-
57.00
123.00
148.00
115
SG&A Expense
7,095.00
10,498.00
20,813.00
28,582.00
30,214.00
21,257
EBIT
7,122.00
7,580.00
20,870.00
28,705.00
30,362.00
21,372
Unusual Expense
-
5,151.00
-
-
-
-
Non Operating Income/Expense
67.00
10,222.00
651.00
14.00
139.00
207
Interest Expense
861.00
857.00
-
-
-
-
Pretax Income
7,912.00
3,342.00
21,377.00
28,526.00
29,964.00
20,729
Consolidated Net Income
7,912.00
3,342.00
21,377.00
28,526.00
29,964.00
20,729
Net Income
7,912.00
3,342.00
21,377.00
28,526.00
29,964.00
20,729
Net Income After Extraordinaries
7,912.00
3,342.00
21,377.00
28,526.00
29,964.00
20,729
Net Income Available to Common
14,031.00
9,695.00
21,377.00
28,526.00
36,711.00
20,729
EPS (Basic)
0.94
3.16
1.30
1.72
2.13
1.15
Basic Shares Outstanding
14,993.90
3,064.50
16,464.10
16,561.80
17,274.30
18,102.20
EPS (Diluted)
0.94
3.16
1.30
1.72
2.13
1.15
Diluted Shares Outstanding
14,993.90
3,064.50
16,464.10
16,561.80
17,274.30
18,102.20
EBITDA
7,095.00
7,550.00
20,813.00
28,582.00
30,214.00
21,257
Non-Operating Interest Income
4.00
24.00
144.00
193.00
259.00
436
Preferred Dividends
6,119.00
6,353.00
-
-
6,747.00
-

About Proteon Therapeutics

View Profile
Address
200 West Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.proteontherapeutics.com
Updated 07/08/2019
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.